AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7502
+0.0002 (0.03%)
At close: Jun 2, 2026, 4:00 PM EDT
0.7276
-0.0226 (-3.01%)
Pre-market: Jun 3, 2026, 4:00 AM EDT
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
19.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curis | 7.06M |
| Traws Pharma | 2.73M |
| Lipocine | 2.00M |
| Longeveron | 1.22M |
| Exicure | 500.00K |
AEON News
- 19 days ago - AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 19 days ago - AEON Biopharma Earnings release: Q1 2026 - Filings
- 19 days ago - AEON Biopharma Quarterly report: Q1 2026 - Filings
- 19 days ago - Aeon Biopharma management to meet virtually with Lake Street - TheFly
- 19 days ago - AEON Biopharma Slides: Corporate presentation - Filings
- 4 weeks ago - AEON Biopharma Proxy statement: Proxy filing - Filings
- 4 weeks ago - AEON Biopharma Proxy statement: Proxy filing - Filings
- 5 weeks ago - AEON Biopharma Sets Annual Shareholder Meeting - GlobeNewsWire